Johannes Setijono - Kalbe Farma President Commissioner
| KLBF Stock | IDR 1,440 35.00 2.49% |
President
Mr. Johannes Setijono serves as the President Commissioner of PT Kalbe Farma Tbk since May 26, 2008. He joined the Company in 1972 as Research Development Manager and was appointed as Director of Marketing in 1976. Between 1992 and 1998, he served as a Commissioner of the Company, as well as that of several other companies in the Kalbe Group, namely as Commissioner of PT Kageo Igar Jaya Tbk, President Commissioner of PT Hexpharm Jaya Laboratories and also as Commissioner PT Sanghiang Perkasa since 1993. Between 1996 and 1998, he served as President Director of PT Enseval Putera Megatrading Tbk. He was the President Commissioner of PT Bintang Toedjoe and a Commissioner of PT Finusolprima Farma. He has also held several senior positions in PT Dankos Laboratories Tbk, including as a Director in 1985, a Commissioner between 1989 and 1994 and President Commissioner from April 1994 until the merger. He also served as President Director of the Company from 1998 until May 26, 2008. He serves as Chairman of the Indonesian Pharmaceutical Association for the period from 2011 until 2016. He holds a degree in Pharmacy from Bandung Institute of Technology in 1969. He is the Chairman of Nomination and Remuneration Committees. since 2008.
| Age | 70 |
| Tenure | 16 years |
| Phone | 62 21 4287 3888 |
| Web | https://www.kalbe.co.id |
Kalbe Farma Management Efficiency
The company has return on total asset (ROA) of 0.106 % which means that it generated a profit of $0.106 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1673 %, meaning that it generated $0.1673 on every $100 dollars invested by stockholders. Kalbe Farma's management efficiency ratios could be used to measure how well Kalbe Farma manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | PRESIDENT Age | ||
| Gatot Trihargo | Bank Rakyat Indonesia | 57 | |
| Paul Janelle | Hanjaya Mandala Sampoerna | 52 | |
| Arif Wibowo | Garuda Indonesia Persero | 48 | |
| Prajogo Pangestu | Barito Pacific Tbk | 72 | |
| Jahja Setiaatmadja | Bank Central Asia | 67 | |
| Hary Tanoesoedibjo | Mnc Land Tbk | 50 | |
| Hexana Sasongko | Bank Rakyat Indonesia | 51 | |
| Charles Bendotti | Hanjaya Mandala Sampoerna | 42 | |
| Muhammad Rustanto | Mnc Land Tbk | 65 | |
| Jusman Djamal | Garuda Indonesia Persero | 62 | |
| Suprajarto | Bank Rakyat Indonesia | 61 | |
| Mindaugas Trumpaitis | Hanjaya Mandala Sampoerna | 43 | |
| Pahala Mansury | Garuda Indonesia Persero | 45 | |
| Djohan Setijoso | Bank Central Asia | 77 | |
| Wahyu Kuncoro | Bank Rakyat Indonesia | 49 | |
| Agus Noorsanto | Bank Rakyat Indonesia | 54 | |
| Saptono Siwi | Bank Rakyat Indonesia | N/A | |
| Bambang Tanoesoedibjo | Mnc Land Tbk | 52 | |
| Rudy Suparman | Barito Pacific Tbk | N/A | |
| Amir Rachman | Mnc Land Tbk | 66 | |
| John Gledhill | Hanjaya Mandala Sampoerna | 65 | |
Management Performance
| Return On Equity | 0.17 | |||
| Return On Asset | 0.11 |
Kalbe Farma Tbk Leadership Team
Elected by the shareholders, the Kalbe Farma's board of directors comprises two types of representatives: Kalbe Farma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Kalbe. The board's role is to monitor Kalbe Farma's management team and ensure that shareholders' interests are well served. Kalbe Farma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Kalbe Farma's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Djonny Tjahyadi, Director | ||
| Lanny Soputro, G HR | ||
| Ferdinand Aryanto, Commissioner | ||
| Santoso Oen, Commissioner | ||
| Ongkie Tedjasurja, Director | ||
| Sie Djohan, Management Devel | ||
| Bernadus Winata, Independent Director, Corporate Secretary | ||
| Johannes Setijono, President Commissioner | ||
| Bujung Nugroho, Director | ||
| Vidjongtius, Director, Corporate Secretary, IR Contact Officer | ||
| Lucky Slamet, Independent Commissioner | ||
| Farid Moeloek, Independent Commissioner | ||
| Kurniawan Suhartono, Head Unit | ||
| Bernadette Setiady, President Director | ||
| Lilis Halim, Independent Commissioner | ||
| Johanes Ibrahim, Independent Commissioner | ||
| Ronny Hadiana, Commissioner | ||
| Lukito Gozali, Head Relations |
Kalbe Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Kalbe Farma a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.17 | |||
| Return On Asset | 0.11 | |||
| Profit Margin | 0.12 % | |||
| Operating Margin | 0.15 % | |||
| Current Valuation | 95.3 T | |||
| Shares Outstanding | 46.26 B | |||
| Shares Owned By Insiders | 58.08 % | |||
| Shares Owned By Institutions | 15.23 % | |||
| Price To Book | 5.06 X | |||
| Price To Sales | 3.36 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kalbe Farma Tbk. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Complementary Tools for Kalbe Stock analysis
When running Kalbe Farma's price analysis, check to measure Kalbe Farma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kalbe Farma is operating at the current time. Most of Kalbe Farma's value examination focuses on studying past and present price action to predict the probability of Kalbe Farma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kalbe Farma's price. Additionally, you may evaluate how the addition of Kalbe Farma to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |